1The PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
2Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH USA
3Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
4Institute of Biochemical Science, National Taiwan University, Taipei, Taiwan
5Epigenome Research Center, China Medical University Hospital, Taichung, Taiwan
6Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
7Department of Pharmacology, College of Medicine, Taipei Medical University, Taipei, Taiwan
8Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.